These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18075729)

  • 1. [Diagnosis and therapy of osteogenesis imperfecta].
    Meurer A; Lewens T; Schmitt D; Vetter T; Drees P
    Orthopade; 2008 Jan; 37(1):17-23. PubMed ID: 18075729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Osteogenesis imperfecta].
    Schuh A; Hönle W; Effenberger H
    MMW Fortschr Med; 2009 Nov; 151(48):38, 40. PubMed ID: 20085061
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteogenesis imperfecta: from diagnosis and multidisciplinary treatment to future perspectives.
    Bregou Bourgeois A; Aubry-Rozier B; Bonafé L; Laurent-Applegate L; Pioletti DP; Zambelli PY
    Swiss Med Wkly; 2016; 146():w14322. PubMed ID: 27346233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebra lines in osteogenesis imperfecta on bisphosphonate therapy.
    Sukumar SP; Balachandran K; Sahoo JP; Kamalanathan S
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23440989
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up in osteogenesis imperfecta type VI.
    Trejo P; Palomo T; Montpetit K; Fassier F; Sato A; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do femoral fractures in adult patients with osteogenesis imperfecta imitate atypical femoral fractures? A case series.
    Andersen JD; Bünger MH; Rahbek O; Hald JD; Harsløf T; Langdahl BL
    Osteoporos Int; 2019 Feb; 30(2):513-517. PubMed ID: 30448959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolendronate in osteogenesis imperfecta.
    Panigrahi I; Das RR; Marwaha RK
    J Pediatr Endocrinol Metab; 2009 Aug; 22(8):763. PubMed ID: 19845128
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental panoramic indices and fractal dimension measurements in osteogenesis imperfecta children under pamidronate treatment.
    Apolinário AC; Sindeaux R; de Souza Figueiredo PT; Guimarães AT; Acevedo AC; Castro LC; de Paula AP; de Paula LM; de Melo NS; Leite AF
    Dentomaxillofac Radiol; 2016; 45(4):20150400. PubMed ID: 26954289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.
    Song Y; Zhao D; Xu X; Lv F; Li L; Jiang Y; Wang O; Xia W; Xing X; Li M
    Osteoporos Int; 2018 Jun; 29(6):1389-1396. PubMed ID: 29520608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate therapy for severe osteogenesis imperfecta.
    Glorieux FH
    J Pediatr Endocrinol Metab; 2000 Sep; 13 Suppl 2():989-92. PubMed ID: 11086652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].
    Chigladze TT; Zhvaniia MA; Bekua MV
    Georgian Med News; 2006 Feb; (131):62-5. PubMed ID: 16575136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PREPARATIONS OF PAMIDRONOVIC ACID IN COMPLEX TREATMENT ON OSTEOGENESIS IMPERFECTA].
    Zyma AM; Guk YM; Magomedov OM; Gayko OG; Kincha-Polishchuk TA
    Klin Khir; 2015 Jul; (7):58-61. PubMed ID: 26591224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.
    Rauch F; Munns C; Land C; Glorieux FH
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1268-74. PubMed ID: 16434452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteogenesis imperfecta.
    Bhadada SK; Santosh R; Bhansali A; Upreti V; Dutta P
    J Assoc Physicians India; 2009 Jan; 57():33-6. PubMed ID: 19753756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in the treatment of osteogenesis imperfecta type III - own experience.
    Jakubowska-Pietkiewicz E; Chlebna-Sokół D
    Ortop Traumatol Rehabil; 2008; 10(6):593-601. PubMed ID: 19153548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C
    Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy.
    Sousa T; Bompadre V; White KK
    J Pediatr Orthop; 2014 Jan; 34(1):118-22. PubMed ID: 23863411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review.
    Sinikumpu JJ; Ojaniemi M; Lehenkari P; Serlo W
    Injury; 2015 Aug; 46(8):1440-6. PubMed ID: 25943292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rare combination of amniotic constriction band with osteogenesis imperfecta.
    Shah KH; Shah H
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26561227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.